Cargando…
Significance of Lipopolysaccharides in Gastric Cancer and Their Potential as a Biomarker for Nivolumab Sensitivity
Lipopolysaccharides are a type of polysaccharide mainly present in the bacterial outer membrane of Gram-negative bacteria. Recent studies have revealed that lipopolysaccharides contribute to the immune response of the host by functioning as a cancer antigen. We retrospectively recruited 198 patients...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380503/ https://www.ncbi.nlm.nih.gov/pubmed/37511547 http://dx.doi.org/10.3390/ijms241411790 |
_version_ | 1785080211395575808 |
---|---|
author | Nakazawa, Nobuhiro Yokobori, Takehiko Sohda, Makoto Hosoi, Nobuhiro Watanabe, Takayoshi Shimoda, Yuki Ide, Munenori Sano, Akihiko Sakai, Makoto Erkhem-Ochir, Bilguun Ogawa, Hiroomi Shirabe, Ken Saeki, Hiroshi |
author_facet | Nakazawa, Nobuhiro Yokobori, Takehiko Sohda, Makoto Hosoi, Nobuhiro Watanabe, Takayoshi Shimoda, Yuki Ide, Munenori Sano, Akihiko Sakai, Makoto Erkhem-Ochir, Bilguun Ogawa, Hiroomi Shirabe, Ken Saeki, Hiroshi |
author_sort | Nakazawa, Nobuhiro |
collection | PubMed |
description | Lipopolysaccharides are a type of polysaccharide mainly present in the bacterial outer membrane of Gram-negative bacteria. Recent studies have revealed that lipopolysaccharides contribute to the immune response of the host by functioning as a cancer antigen. We retrospectively recruited 198 patients with gastric cancer who underwent surgery. The presence of lipopolysaccharides was determined using immunohistochemical staining, with the intensity score indicating positivity. The relationship between lipopolysaccharides and CD8, PD-L1, TGFBI (a representative downstream gene of TGF-β signaling), wnt3a, and E-cadherin (epithelial–mesenchymal transition marker) was also investigated. Thereafter, we identified 20 patients with advanced gastric cancer receiving nivolumab and investigated the relationship between lipopolysaccharides and nivolumab sensitivity. After staining for lipopolysaccharides in the nucleus of cancer cells, 150 negative (75.8%) and 48 positive cases (24.2%) were found. The lipopolysaccharide-positive group showed increased cancer stromal TGFBI expression (p < 0.0001) and PD-L1 expression in cancer cells (p = 0.0029). Lipopolysaccharide positivity was significantly correlated with increased wnt3a signaling (p = 0.0028) and decreased E-cadherin expression (p = 0.0055); however, no significant correlation was found between lipopolysaccharide expression and overall survival rate (p = 0.71). In contrast, high TGFBI expression in the presence of LPS was associated with a worse prognosis than that in the absence of LPS (p = 0.049). Among cases receiving nivolumab, the lipopolysaccharide-negative and -positive groups had disease control rates of 66.7% and 11.8%, respectively (p = 0.088). Lipopolysaccharide positivity was associated with wnt3a, TGF-β signaling, and epithelial–mesenchymal transition and was considered to tend to promote therapeutic resistance to nivolumab. |
format | Online Article Text |
id | pubmed-10380503 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103805032023-07-29 Significance of Lipopolysaccharides in Gastric Cancer and Their Potential as a Biomarker for Nivolumab Sensitivity Nakazawa, Nobuhiro Yokobori, Takehiko Sohda, Makoto Hosoi, Nobuhiro Watanabe, Takayoshi Shimoda, Yuki Ide, Munenori Sano, Akihiko Sakai, Makoto Erkhem-Ochir, Bilguun Ogawa, Hiroomi Shirabe, Ken Saeki, Hiroshi Int J Mol Sci Article Lipopolysaccharides are a type of polysaccharide mainly present in the bacterial outer membrane of Gram-negative bacteria. Recent studies have revealed that lipopolysaccharides contribute to the immune response of the host by functioning as a cancer antigen. We retrospectively recruited 198 patients with gastric cancer who underwent surgery. The presence of lipopolysaccharides was determined using immunohistochemical staining, with the intensity score indicating positivity. The relationship between lipopolysaccharides and CD8, PD-L1, TGFBI (a representative downstream gene of TGF-β signaling), wnt3a, and E-cadherin (epithelial–mesenchymal transition marker) was also investigated. Thereafter, we identified 20 patients with advanced gastric cancer receiving nivolumab and investigated the relationship between lipopolysaccharides and nivolumab sensitivity. After staining for lipopolysaccharides in the nucleus of cancer cells, 150 negative (75.8%) and 48 positive cases (24.2%) were found. The lipopolysaccharide-positive group showed increased cancer stromal TGFBI expression (p < 0.0001) and PD-L1 expression in cancer cells (p = 0.0029). Lipopolysaccharide positivity was significantly correlated with increased wnt3a signaling (p = 0.0028) and decreased E-cadherin expression (p = 0.0055); however, no significant correlation was found between lipopolysaccharide expression and overall survival rate (p = 0.71). In contrast, high TGFBI expression in the presence of LPS was associated with a worse prognosis than that in the absence of LPS (p = 0.049). Among cases receiving nivolumab, the lipopolysaccharide-negative and -positive groups had disease control rates of 66.7% and 11.8%, respectively (p = 0.088). Lipopolysaccharide positivity was associated with wnt3a, TGF-β signaling, and epithelial–mesenchymal transition and was considered to tend to promote therapeutic resistance to nivolumab. MDPI 2023-07-22 /pmc/articles/PMC10380503/ /pubmed/37511547 http://dx.doi.org/10.3390/ijms241411790 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Nakazawa, Nobuhiro Yokobori, Takehiko Sohda, Makoto Hosoi, Nobuhiro Watanabe, Takayoshi Shimoda, Yuki Ide, Munenori Sano, Akihiko Sakai, Makoto Erkhem-Ochir, Bilguun Ogawa, Hiroomi Shirabe, Ken Saeki, Hiroshi Significance of Lipopolysaccharides in Gastric Cancer and Their Potential as a Biomarker for Nivolumab Sensitivity |
title | Significance of Lipopolysaccharides in Gastric Cancer and Their Potential as a Biomarker for Nivolumab Sensitivity |
title_full | Significance of Lipopolysaccharides in Gastric Cancer and Their Potential as a Biomarker for Nivolumab Sensitivity |
title_fullStr | Significance of Lipopolysaccharides in Gastric Cancer and Their Potential as a Biomarker for Nivolumab Sensitivity |
title_full_unstemmed | Significance of Lipopolysaccharides in Gastric Cancer and Their Potential as a Biomarker for Nivolumab Sensitivity |
title_short | Significance of Lipopolysaccharides in Gastric Cancer and Their Potential as a Biomarker for Nivolumab Sensitivity |
title_sort | significance of lipopolysaccharides in gastric cancer and their potential as a biomarker for nivolumab sensitivity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380503/ https://www.ncbi.nlm.nih.gov/pubmed/37511547 http://dx.doi.org/10.3390/ijms241411790 |
work_keys_str_mv | AT nakazawanobuhiro significanceoflipopolysaccharidesingastriccancerandtheirpotentialasabiomarkerfornivolumabsensitivity AT yokoboritakehiko significanceoflipopolysaccharidesingastriccancerandtheirpotentialasabiomarkerfornivolumabsensitivity AT sohdamakoto significanceoflipopolysaccharidesingastriccancerandtheirpotentialasabiomarkerfornivolumabsensitivity AT hosoinobuhiro significanceoflipopolysaccharidesingastriccancerandtheirpotentialasabiomarkerfornivolumabsensitivity AT watanabetakayoshi significanceoflipopolysaccharidesingastriccancerandtheirpotentialasabiomarkerfornivolumabsensitivity AT shimodayuki significanceoflipopolysaccharidesingastriccancerandtheirpotentialasabiomarkerfornivolumabsensitivity AT idemunenori significanceoflipopolysaccharidesingastriccancerandtheirpotentialasabiomarkerfornivolumabsensitivity AT sanoakihiko significanceoflipopolysaccharidesingastriccancerandtheirpotentialasabiomarkerfornivolumabsensitivity AT sakaimakoto significanceoflipopolysaccharidesingastriccancerandtheirpotentialasabiomarkerfornivolumabsensitivity AT erkhemochirbilguun significanceoflipopolysaccharidesingastriccancerandtheirpotentialasabiomarkerfornivolumabsensitivity AT ogawahiroomi significanceoflipopolysaccharidesingastriccancerandtheirpotentialasabiomarkerfornivolumabsensitivity AT shirabeken significanceoflipopolysaccharidesingastriccancerandtheirpotentialasabiomarkerfornivolumabsensitivity AT saekihiroshi significanceoflipopolysaccharidesingastriccancerandtheirpotentialasabiomarkerfornivolumabsensitivity |